Acute Porphyria Drug Database

Monograph

V03AF01 - Mesna
Propably not porphyrinogenic
PNP

Rationale
Non-hepatic, probably non-CYP metabolism.
Chemical description
Sodium mercaptethane sulfonate administered during treatment with iophosphamide in order to counteract urinary tract toxicity caused by acroleine formed. Converted to free thiol in serum and eliminated in urine.
Similar drugs
Explore alternative drugs in similar therapeutic classes V03A / V03AF or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Uromitexan Uromitexan Mesna · Uromitexan Uromitexan Uromitexan Mesna · Uromitexan Uromitexan Uromitexan Uromitexan Uromitexan Uromitexan Uromitexan Uromitexan
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙